rs376538590
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005548.3(KARS1):āc.1438G>Cā(p.Glu480Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005548.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KARS1 | NM_005548.3 | c.1438G>C | p.Glu480Gln | missense_variant | 12/14 | ENST00000302445.8 | NP_005539.1 | |
KARS1 | NM_001130089.2 | c.1522G>C | p.Glu508Gln | missense_variant | 13/15 | NP_001123561.1 | ||
KARS1 | NM_001378148.1 | c.970G>C | p.Glu324Gln | missense_variant | 12/14 | NP_001365077.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KARS1 | ENST00000302445.8 | c.1438G>C | p.Glu480Gln | missense_variant | 12/14 | 1 | NM_005548.3 | ENSP00000303043 | A1 | |
KARS1 | ENST00000319410.9 | c.1522G>C | p.Glu508Gln | missense_variant | 13/15 | 1 | ENSP00000325448 | P4 | ||
KARS1 | ENST00000568378.5 | c.147-1539G>C | intron_variant | 5 | ENSP00000454512 | |||||
KARS1 | ENST00000564578.5 | c.*981G>C | 3_prime_UTR_variant, NMD_transcript_variant | 12/14 | 5 | ENSP00000455818 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251456Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135900
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461776Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727182
GnomAD4 genome AF: 0.000138 AC: 21AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 31, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Glu508Gln var iant in KARS has not been previously reported in individuals with hearing loss, but has been identified in 6/10390 of African chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs376538590). Althoug h this variant has been seen in the general population, its frequency is not hig h enough to rule out a pathogenic role. Glutamic acid (Glu) at position 508 is n ot conserved in mammals or evolutionarily distant species and 8 species (tenrec, rock pigeon, american alligator, lizard, and 4 turtle species) carry a glutamin e (Gln) at this position, raising the possibility that this change may be tolera ted. Additional computational prediction tools suggest that the p.Glu508Gln vari ant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p .Glu508Gln variant is uncertain, its presence in other species suggests that it is more likely to be benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.1522G>C (p.E508Q) alteration is located in exon 13 (coding exon 12) of the KARS gene. This alteration results from a G to C substitution at nucleotide position 1522, causing the glutamic acid (E) at amino acid position 508 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 508 of the KARS protein (p.Glu508Gln). This variant is present in population databases (rs376538590, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with KARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 228756). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at